Back | Next |
home / stock / innmf / innmf message board
Subject | By | Source | When |
---|---|---|---|
Is this not the most screwed up reverse | Smilin_B | investorshub | 05/04/2018 4:43:00 PM |
ASX RELEASE 4 May 2018 | Smilin_B | investorshub | 05/04/2018 1:35:13 AM |
$INNMF: OS now 22Million | makinezmoney | investorshub | 05/03/2018 4:14:04 PM |
Thanks! | LexTrader | investorshub | 05/03/2018 1:54:40 AM |
$INNMF on daily list today 1:10 RS | gumzsa | investorshub | 05/03/2018 1:52:19 AM |
yup, but nothing from FINRA only the DTC | LexTrader | investorshub | 04/30/2018 7:05:23 PM |
1 for 10 R/S | racerdave42 | investorshub | 04/30/2018 7:03:57 PM |
$INNMF looking strong this morning! | LexTrader | investorshub | 04/30/2018 1:41:08 PM |
ELEASE 26 April 2018 | Smilin_B | investorshub | 04/26/2018 5:51:46 AM |
Double from here .. building flag | deadjim | investorshub | 03/28/2018 2:38:59 PM |
Did I read this correctly that they are | schaub | investorshub | 03/23/2018 9:17:34 PM |
$INNMF: Actually Australias Shares were up by 355% | makinezmoney | investorshub | 03/23/2018 5:54:32 PM |
$INNMF are you watching L2? ;) | BCNstocks | investorshub | 03/23/2018 5:47:40 PM |
Got in @.04 Thanks | Richbaby | investorshub | 03/23/2018 2:15:20 PM |
$INNMF: Not gonna dip now.... was $0.45 last June | makinezmoney | investorshub | 03/23/2018 2:13:06 PM |
$INNMF: Price in Australia closed over 150% overnight | makinezmoney | investorshub | 03/23/2018 1:31:44 PM |
Thank you buddy | Richbaby | investorshub | 03/23/2018 1:25:59 PM |
First big dip. Probably will be above | deadjim | investorshub | 03/23/2018 1:24:40 PM |
?? Im newbie ?? Ok thanks | Richbaby | investorshub | 03/23/2018 1:23:11 PM |
$INNMF: Read my post from March 12, 2018 | makinezmoney | investorshub | 03/23/2018 1:15:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Amplia Therapeutics Ltd Company Name:
INNMF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Chris Burns joins Proactive’s Jonathan Jackson to discuss the company’s busy quarter and what investors can expect over the coming months. Burns talks us through the completion of the Phase1B stage of the ACCENT clinical trial i...
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns tells Proactive the company has received grant funding to undertake a research collaboration with Australia’s national science agency to develop topical formulations of its FAK inhibitors. Amplia will work with resea...
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns speaks with Proactive following his move into the leadership role late last year. Amplia is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an ...